Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
Clinical trial NCT04006119 · TERMINATED
Trial details
- NCT number
- NCT04006119
- Sponsor
- Alaunos Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2021-08-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.